| Financial Year |
March 31 2023 |
| Monetary Funds |
72,684,070.67 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,123,649.34 |
| Accounts Receivable |
797,134,419.37 |
| Advances to Suppliers |
8,317,916.89 |
| Other Receivables |
26,542,793.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
141,742,150.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,946,270.96 |
| Total Current Assets |
1,100,984,169.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
155,990,972.48 |
| Investment Properties |
-- |
| Fixed Assetes |
119,131,704.99 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
110,454,809.41 |
| R&D expenses |
-- |
| Goodwill |
1,059,486,925.88 |
| Long-Term Deferred and Prepaid Expenses |
2,731,464.42 |
| Deferred Income Tax Assets |
80,125,963.38 |
| Other Non-Current Assets |
2,879,698.58 |
| Sub-Total of Non-Current Assets |
1,682,221,832.61 |
| Total Assets |
2,783,206,001.80 |
| Short-Term Loans |
138,014,480.95 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,205,505.37 |
| Accounts Payable |
104,305,187.27 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
28,979,115.93 |
| Taxes Payable |
10,415,276.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,248,250.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,829,531.26 |
| Other Current Liabilities |
4,238,458.43 |
| Sub-Total of Current Liabilities |
385,534,644.93 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,169,715.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
60,069,277.34 |
| Total Liabilities |
445,603,922.27 |
| Paid-In Capital(Or Share Stock) |
460,698,732.00 |
| Capital Surplus |
1,184,838,377.34 |
| Surplus Reserve |
71,574,863.12 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
529,378,982.36 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,337,602,079.53 |
| Owner's Equity（Stockholder's Equity） |
2,337,602,079.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,783,206,001.80 |
